TY - JOUR
T1 - Heterogeneity of antigen expression explains controversy over glomerular macrophage accumulation in mouse glomerulonephritis
AU - Masaki, Takao
AU - Chow, Fiona YF
AU - Nikolic-Paterson, David J
AU - Atkins, Robert Charles
AU - Tesch, Gregory H
PY - 2003
Y1 - 2003
N2 - SUMMARY:
Interleukin-10 (IL-10) has been recognized as a growth factor for rat mesangial cells
in
vitro
; however, its role in mesangioproliferative glomerulonephritis is unknown. We studied the expression
of IL-10 mRNA in the rat anti-Thy-1 model of mesangioproliferative glomerulonephritis (experiment
1) and, subsequently, the effects of blocking IL-10 during anti-Thy-1 nephritis using the IL-10
inhibitor, AS101 (experiment 2). In experiment 1, PCR analysis failed to detect IL-10 mRNA in normal
rat kidney, however, a clear signal for IL-10 mRNA was evident on day 6 of anti-Thy-1 nephritis.
In situ
hybridization showed IL-10 mRNA expression in focal glomerular areas in anti-Thy-1 nephritis. Combined
in situ
hybridization and immunohistochemistry showed that glomerular IL-10 mRNA was
expressed by both macrophages and mesangial cells. In experiment 2, treatment with AS101 significantly
downregulated renal IL-10 gene expression, as demonstrated by semiquantitative PCR. However,
the induction of glomerular hypercellularity, mesangial proliferation (PCNA
+
cells), mesangial cell
activation (
I?
-SMA expression) and macrophage accumulation (ED1
+
cells) seen in saline-treated anti-
Thy-1 nephritis was unaffected by AS101 treatment. In conclusion, renal IL-10 gene expression is
upregulated during pathological mesangial cell proliferation in rats with anti-Thy-1 nephritis. However,
the inability of IL-10 suppression with AS101 to prevent anti-Thy-1 disease suggests that IL-10 is not
essential for pathological mesangial cell proliferation.
AB - SUMMARY:
Interleukin-10 (IL-10) has been recognized as a growth factor for rat mesangial cells
in
vitro
; however, its role in mesangioproliferative glomerulonephritis is unknown. We studied the expression
of IL-10 mRNA in the rat anti-Thy-1 model of mesangioproliferative glomerulonephritis (experiment
1) and, subsequently, the effects of blocking IL-10 during anti-Thy-1 nephritis using the IL-10
inhibitor, AS101 (experiment 2). In experiment 1, PCR analysis failed to detect IL-10 mRNA in normal
rat kidney, however, a clear signal for IL-10 mRNA was evident on day 6 of anti-Thy-1 nephritis.
In situ
hybridization showed IL-10 mRNA expression in focal glomerular areas in anti-Thy-1 nephritis. Combined
in situ
hybridization and immunohistochemistry showed that glomerular IL-10 mRNA was
expressed by both macrophages and mesangial cells. In experiment 2, treatment with AS101 significantly
downregulated renal IL-10 gene expression, as demonstrated by semiquantitative PCR. However,
the induction of glomerular hypercellularity, mesangial proliferation (PCNA
+
cells), mesangial cell
activation (
I?
-SMA expression) and macrophage accumulation (ED1
+
cells) seen in saline-treated anti-
Thy-1 nephritis was unaffected by AS101 treatment. In conclusion, renal IL-10 gene expression is
upregulated during pathological mesangial cell proliferation in rats with anti-Thy-1 nephritis. However,
the inability of IL-10 suppression with AS101 to prevent anti-Thy-1 disease suggests that IL-10 is not
essential for pathological mesangial cell proliferation.
UR - http://ndt.oxfordjournals.org/cgi/reprint/18/1/178
M3 - Article
SN - 0931-0509
VL - 18
SP - 178
EP - 181
JO - Nephrology Dialysis Transplantation
JF - Nephrology Dialysis Transplantation
IS - 1
ER -